Health
SARS-CoV-2 vaccines from Pfizer-BioNTech and AstraZeneca reduce mortality among the elderly – News-Medical.net
Researchers in the UK have demonstrated the efficacy of the Pfizer-BioNTech and AstraZeneca vaccines against severe acute respiratory virus coronavirus 2 (SARS-CoV-2)…
Researchers in the UK have demonstrated the efficacy of the Pfizer-BioNTech and AstraZeneca vaccines against severe acute respiratory virus coronavirus 2 (SARS-CoV-2) at preventing death among older individuals with coronavirus disease 2019 (COVID-19).
The analysis of more than 48,000 individuals, aged 70 years and older, found that COVID-19 cases who had been vaccinated with one dose of Pfizer-BioNTech’s BNT162b2 vaccine were at a 44% reduced risk of death, compared with unvaccinated individuals,…
Continue Reading
